Furthermore, patients with severe COVID-19 exhibit not only lower numbers of cytotoxic CD8+ T cells but also a decreased capacity to produce IFN-γ and perforin (Mazzoni et al., 2020). This evidence concerns the gene PRF1 and COVID-19.